Commentary on systematic review, economic, and financial analysis submitted to Pharmaceutical Benefits Advisory committee (PBAC) #1 in 2022

Research output: Book/Report › Commissioned report › peer-review

Original language	English
Publisher	Australian Government Department of Health
Commissioning body	Department of Health, Disability and Ageing (Commonwealth)
Number of pages	103
Publication status	Published - 2022

Cite this

TY - BOOK

T1 - Commentary on systematic review, economic, and financial analysis submitted to Pharmaceutical Benefits Advisory committee (PBAC) #1 in 2022

AU - Rana, Rezwanul

AU - Hoyle, Martin

PY - 2022

Y1 - 2022

M3 - Commissioned report

BT - Commentary on systematic review, economic, and financial analysis submitted to Pharmaceutical Benefits Advisory committee (PBAC) #1 in 2022

PB - Australian Government Department of Health

ER -